MEF2C and Alzheimer disease: On the other hand, a recent report shows that the decrease of MEF2C-mediated neuronal transcription by the activation of microglial cyclic GMP–AMP synthase and type I interferon (IFN-I) signaling declines cognitive function in AD [17].